Law.com Subscribers SAVE 30%

Call 855-808-4530 or email [email protected] to receive your discount on a new subscription.

Employment Law StrategistEmployment LitigationFeaturesLJN Newsletters

Medical Marijuana

By Stephanie Dutchess Trudeau
September 02, 2017

Here is the latest tip for employers: Do not be too quick to “just say no” to medical marijuana. The answer that “we follow federal law” is not so easy anymore. The “it's a federal crime” escape hatch employers invoked previously has been closed by more and more courts in states with medical marijuana laws. It is a welcome opportunity for employers that were not comfortable making employees choose between keeping their jobs or keeping a medical treatment.

The conflict between federal law outlawing marijuana and state laws legalizing medical marijuana led many employers to believe the safest policy was to prohibit employee use of medical marijuana. Some employers felt they had little choice but to say no. If they allowed it and an employee who used medical marijuana caused injury or harm, the employer's decision not to follow federal law would be questioned as unwise or, worse yet, deemed reason for liability. Some employers assumed that federal law trumped state law. But the landscape has changed.

This premium content is locked for Employment Law Strategist subscribers only

  • Stay current on the latest information, rulings, regulations, and trends
  • Includes practical, must-have information on copyrights, royalties, AI, and more
  • Tap into expert guidance from top entertainment lawyers and experts

For enterprise-wide or corporate acess, please contact Customer Service at [email protected] or 877-256-2473

Read These Next
The DOJ's Corporate Enforcement Policy: One Year Later Image

The DOJ's Criminal Division issued three declinations since the issuance of the revised CEP a year ago. Review of these cases gives insight into DOJ's implementation of the new policy in practice.

Use of Deferred Prosecution Agreements In White Collar Investigations Image

This article discusses the practical and policy reasons for the use of DPAs and NPAs in white-collar criminal investigations, and considers the NDAA's new reporting provision and its relationship with other efforts to enhance transparency in DOJ decision-making.

The DOJ's New Parameters for Evaluating Corporate Compliance Programs Image

The parameters set forth in the DOJ's memorandum have implications not only for the government's evaluation of compliance programs in the context of criminal charging decisions, but also for how defense counsel structure their conference-room advocacy seeking declinations or lesser sanctions in both criminal and civil investigations.

CLE Shouldn't Be the Only Mandatory Training for Attorneys Image

Each stage of an attorney's career offers opportunities for a curriculum that addresses both the individual's and the firm's need to drive success.

A defendant in a patent infringement suit may, during discovery and prior to a <i>Markman</i> hearing, compel the plaintiff to produce claim charts, claim constructions, and element-by-element infringement analyses.